1. Home
  2. SHCO vs HROW Comparison

SHCO vs HROW Comparison

Compare SHCO & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SHCO

Soho House & Co Inc.

HOLD

Current Price

$8.96

Market Cap

1.7B

ML Signal

HOLD

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$50.76

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SHCO
HROW
Founded
1995
1998
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.4B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
SHCO
HROW
Price
$8.96
$50.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
8
Target Price
$9.00
$68.86
AVG Volume (30 Days)
573.3K
536.8K
Earning Date
11-07-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,288,973,000.00
$250,042,000.00
Revenue This Year
$11.89
$38.96
Revenue Next Year
$7.87
$43.38
P/E Ratio
N/A
N/A
Revenue Growth
8.48
47.83
52 Week Low
$4.77
$20.85
52 Week High
$8.97
$51.30

Technical Indicators

Market Signals
Indicator
SHCO
HROW
Relative Strength Index (RSI) 69.14 66.32
Support Level $8.94 $44.19
Resistance Level $8.97 $50.65
Average True Range (ATR) 0.03 2.32
MACD 0.01 0.20
Stochastic Oscillator 94.74 88.98

Price Performance

Historical Comparison
SHCO
HROW

About SHCO Soho House & Co Inc.

Soho House & Co Inc is a membership platform of physical and digital spaces that connects a vibrant, diverse group of members from across the world. The members use the platform to work, socialize, connect, create, and flourish all over the world. It offers lease agreements for Houses, hotels, restaurants, studios, spas, and other properties. The company's reportable segments are: United Kingdom; The Americas; and Europe and Rest of the world. The majority of its revenue is generated from the Americas segment, which encompasses its operating units in the Americas, including Soho Houses, stand-alone U.S. restaurants, Soho Friends, and the management fees under a hotel management contract for the operation of The Ned London.

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

Share on Social Networks: